Cigna Stock News

Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, hurt by higher medical costs for a type of employer-sponsored healthcare plan.

The Cigna Group Thursday reported more than $3.4 billion in 2024 net income including $1.4 billion in the fourth quarter as the health insurer worked to overcome rising medical expenses in its employer plans.

Total revenues for 2024 increased 27% to $247.1 billion Shareholders' net income for 2024 was $3.4 billion, or $12.12 per share Adjusted income from operations1 for 2024 was $7.7 billion, or $27.33 per share 2025 adjusted income from operations1,2 is projected to be at least $7.9 billion, or at least $29.50 per share Board of Directors declared an 8% increase in the quarterly dividend to $1.51 ...

Greater Flexibility, More Health Care Options for Customers LOS ANGELES , Jan. 29, 2025 /PRNewswire/ -- Cigna Healthcare and Providence are expanding their Los Angeles County network, offering customers several additional care facilities. Through this agreement, Cigna Healthcare Select HMO customers now have even more options for affordable, in-network care with almost 2,000 providers and speci...

Cigna's unit Evernorth Health said on Wednesday it will take several steps to help lower out-of-pocket cost of prescription drugs for patients at its pharmacy stores.

Actions aim to lower patient out-of-pocket costs Expands transparency for both patients and those who provide their benefits BLOOMFIELD, Conn. , Jan. 29, 2025 /PRNewswire/ -- Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), today announced several steps it is taking to improve costs and transparency around pharmacy benefits.

The Q4 earnings season continued on a positive note after big banks and other financials struck a bullish tone in the first two weeks of reporting. Highly anticipated reports from the Magnificent 7 will be in focus over the next couple of weeks. Southwest Airlines is set to report their Q4 2024 results on Thursday, January 30, a week later than expected.

Cigna's current valuation presents a compelling opportunity, trading at a forward PE of 9.9, significantly below its historical average of 12.0x. The company carries diversified revenue streams and consistent earnings growth, with Healthcare and Evernorth divisions driving strong performance and a 13% EPS CAGR over 10 years. Management targets 10-14% long-term annual EPS growth, supported by in...